Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 72   

Articles published

ENZN 1.22 0.00 (0.00%)
price chart
Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)
Compared to other companies in the Biotechnology industry and the overall market, ENZON PHARMACEUTICALS INC's return on equity significantly exceeds that of both the industry average and the S&P 500.
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) Still on Royalty-Driven Autopilot
Enzon Pharmaceuticals Inc (NASDAQ:ENZN, ENZN message board) published a 10-Q report for the quarter ended Mar. 31, 2015 last week, only a few weeks after ENZN hit a 52-week high on the charts, became overbought and subsided again.
Closing Bell Reports: Enzon Pharmaceuticals Inc. (ENZN), SunTrust Banks, Inc ...  WallStreet Scope
Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for January ...
will begin trading ex-dividend on January 08, 2015. A cash dividend payment of $0.1 per share is scheduled to be paid on January 28, 2015.
Health of Health Care Stocks: Complementary Research on Enzon ...
According to an article on Insider Monkey published on April 1, 2015, Enzon Pharmaceuticals Inc., the $46.39 million Company, is currently waiting to be acquired by another concern as it has put brakes on the clinical research and is instead banking on ...
Enzon Pharmaceuticals Moves Past the Tipping Point (ENZN)
If you're looking for a specific reason Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) is charging higher today, don't bother - you won't find one.
Stocks Flashing a Sell Signal: Netflix, Inc. (NASDAQ:NFLX), Enzon ...  Wall Street Observer
Mid-Day Changers: Enzon Pharmaceuticals Inc. (ENZN), Party City Holdco Inc ...  WallStreet Scope
Enzon Pharmaceuticals (ENZN) Weak On High Volume Today
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Enzon Pharmaceuticals ( ENZN) as a weak on ...
Healthcare Stocks Notable Movers- Oncolytics Biotech, Inc. (USA) (ONCY ...
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) updated that following submission to the U.S. Food and Drug Administration (“FDA”) for review, the Investigational New Drug Application containing the protocol titled “MC1472: Phase 1 Study of Replication ...
The Window of Opportunity Opens for Enzon Pharmaceuticals (ENZN)
Last Thursday, yours truly pointed out Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) had just sent a message to the trading world that it was in a bullish mood, and mode.
Morning Buzz: Baker Hughes Incorporated (BHI), Enzon Pharmaceuticals Inc ...  WallStreet Scope
Hot Stocks - Enzon Pharmaceuticals (ENZN), Home Depot (HD), BlackBerry ...  Techsonian (press release)
Technical Scrutiny on Biotech Stocks -- ARIAD Pharma, Array BioPharma, Enzon ...
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Array BioPharma Inc. (NASDAQ: ARRY), Enzon Pharmaceuticals Inc. (NASDAQ: ENZN), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), and ...
Stocks generating high income on investments: Enzon Pharmaceuticals Inc ...
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) was able to keep return on assets at 136.60% in the trailing twelve month while Reuters data showed that industry's average stands at -420.80% and sector's optimum level is 8.53%.
Morning Investor Watch: Juniper Networks, Inc. (JNPR), Enzon Pharmaceuticals ...  WallStreet Scope
Stocks in Action - Enzon Pharmaceuticals (ENZN),Gilead Sciences, (GILD ...  Techsonian (press release)